A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

An ancient molecule that existed long before the circulatory system evolved has been found to support cancer immunotherapy. Researchers at Nagoya University in Japan found that complement C3 protein ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from researchers at the Hackensack Meridian Center for Discovery and Innovation ...

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it ...

In the study, published in Nature Cancer, investigators dove deep into the molecular biology of non-small cell lung cancer to pinpoint what happens on a cellular and molecular level over time when the ...

Dr. Monty Pal discusses his approach to selecting second-line therapy for advanced renal cell carcinoma (RCC) based on the type of first-line immunotherapy regimen previously received. He explains ...

Immunotherapy is a class of medical treatments that harness, enhance, or redirect the body's immune system to fight disease. In its most prominent application – cancer treatment – immunotherapy works ...

Immunotherapy is rapidly redefining curative-intent treatment for localized MSI CRC. Across multiple neoadjuvant studies, short-course PD-1–based therapy, alone or as dual checkpoint inhibitor, has ...

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...